Major advances in the treatment of HIV-1 infection.
Eight drugs are now marketed in the UK for the treatment of human immunodeficiency virus (HIV) infection. Here we discuss these drugs and review the evidence that they delay HIV disease progression and prolong survival.
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D015497:HIV-1; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D011480:Protease Inhibitors